BL
GSK icon

BFSG LLC’s GSK GSK Stock Holding History

BFSG LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$11K – 782
2026
Q1 		$11K Hold
200
– – ﹤0.01% 552
2025
Q4 		$9.81K Buy
+200
New +$9.33K ﹤0.01% 546
2021
Q2 		– Sell
-28,282
Closed -$1.26M – 160
2021
Q1 		$1.26M Sell
28,282
-1,640
-5% -$74.4K 0.2% 113
2020
Q4 		$1.38M Sell
29,922
-571
-2% -$26.2K 0.23% 103
2020
Q3 		$1.44M Sell
30,493
-32
-0.1% -$1.6K 0.27% 92
2020
Q2 		$1.56M Hold
30,525
– – 0.34% 82
2020
Q1 		$1.45M Sell
30,525
-1,388
-4% -$74K 0.37% 81
2019
Q4 		$1.87M Sell
31,913
-80
-0.3% -$4.45K 0.35% 84
2019
Q3 		$1.65M Buy
+31,993
New +$1.65M 0.37% 80

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BFSG LLC's GSK Position: Q2 2026 in Review

BFSG LLC sold out of GSK (GSK) in Q2 2026, closing a stake of 200 shares — an estimated $11K sold.

BFSG LLC first reported a position in GSK in Q3 2019 and held it in 9 quarters. The position peaked at $1.87M in Q4 2019. 1,039 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • BFSG LLC reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • BFSG LLC sold 200 GSK shares in Q2 2026, an estimated $11K.
  • BFSG LLC first reported a position in GSK in Q3 2019 and held it in 9 quarters.
  • BFSG LLC's GSK position peaked at $1.87M in Q4 2019.
  • 1,039 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.